Stock BETRF BETTERLIFE PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News BetterLife Pharma Inc.

Equities

BETRF

CA08772P2026

Market Closed - OTC Markets
Other stock markets
 15:51:39 26/06/2024 BST 		5-day change 1st Jan Change
0.08 USD -4.76% Intraday chart for BetterLife Pharma Inc. -11.70% +66.67%
06-14 BetterLife Pharma Raises $530,000 in Private Placement MT
06-14 BetterLife Pharma Inc. announced that it has received CAD 0.53 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BetterLife Pharma : MANAGEMENT'S DISCUSSION AND ANALYSIS Form 6 K
PU
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
GL
BetterLife Pharma : MATERIAL CHANGE REPORT Form 6 K
PU
BetterLife Pharma Raises $530,000 in Private Placement
MT
BetterLife Announces Closing of a Private Placement
GL
BetterLife Pharma Inc. announced that it has received CAD 0.53 million in funding
CI
BetterLife Pharma Inc. Reports Earnings Results for the Full Year Ended January 31, 2024
CI
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
GL
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
CI
BetterLife Announces Intent to Complete Private Placement of Units
AQ
BetterLife Announces Intent to Complete Private Placement of Units
GL
BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding
CI
BetterLife Pharma Advances IND-enabling Studies For BETR-001
MT
BetterLife Advances BETR-001 IND-enabling Studies
GL
BetterLife Advances BETR-001 IND-enabling Studies
AQ
BetterLife Pharma Inc. Advances BETR-001 IND-Enabling Studies
CI
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
NE
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
GL
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
AQ
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BETRF Stock
  4. News BetterLife Pharma Inc.